Stay updated on Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page.

Latest updates to the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision: v3.6.6 replaces the previous Revision: v3.6.5 on the study page, signaling a minor update to the version history of the record.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedVersion tag updated from v3.6.4 to v3.6.5 on the page, signaling a follow-up update to the record. This is a minor metadata change and does not modify the study data or content shown.SummaryDifference0.1%

- Check54 days agoChange DetectedThe study record history now includes a new revision entry labeled v3.6.4. This revision replaces the previous v3.6.3 entry, reflecting an updated submission to the record.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page's revision indicator was updated to Revision: v3.6.3, replacing the prior Revision: v3.6.2. This reflects a metadata-level update to the study record without altering the study data or reported content.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page shows an updated site revision from v3.6.0 to v3.6.2, reflecting a platform update behind the page rather than changes to the study content.SummaryDifference0.1%

- Check97 days agoChange DetectedThe study record now indicates that recruitment is closed to accrual. Additionally, new help/navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study), and the footer revision note updated to Revision: v3.6.0, with a minor formatting change to the Intervention/Treatment label.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page.